Pegasus Asset Management, Inc. Biogen Inc. Transaction History

Pegasus Asset Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 24, 2019	SELL	$216.71 - $338.96 $987,330 - $1.54 Million	-4,556 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$278.5 - $352.75 $39,825 - $50,443	143 Added 3.24%	4,556 $1.37 Million
Q3 2018 Nov 05, 2018	BUY	$293.51 - $383.83 $6,163 - $8,060	21 Added 0.48%	4,413 $1.56 Million
Q2 2018 Jul 27, 2018	BUY	$257.52 - $306.91 $36,310 - $43,274	141 Added 3.32%	4,392 $1.28 Million
Q1 2018 May 01, 2018	BUY	$260.13 - $367.91 $92,346 - $130,608	355 Added 9.11%	4,251 $1.16 Million
Q4 2017 Feb 12, 2018	BUY	$307.64 - $344.58 $1.2 Million - $1.34 Million	3,896	3,896 $1.24 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Pegasus Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Pegasus Asset Management, Inc. with notifications on news.